alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-D-Glu-OH

Term ID

CHEBI:152991

Synonyms

(2S,3R,4R,5R)-4-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxyhexane-1,2,3,5,6-pentol
6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)-D-glucitol
alpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)-D-glucitol
WURCS=2.0/3,3,2/[h2122h][a2112h-1b_1-5][a1221m-1a_1-5]/1-2-3/a4-b1_b2-c1

Definition

A glycosyl alditol derivative consisting of an alpha-L-fucopyranosyl residue, a beta-D-galactopyranosyl residue and D-glucitol joined in sequence by (1->2) and (1->4) glycosidic bonds.

References

GlyGen:G65070LF
GlyTouCan:G65070LF

Ontology

ChEBI ( EBI )

Relationships

is a type of: glycosyl alditol derivative

glycosyl alditol derivative Show first 5 Terms
has_functional_parent: alpha-L-Fucp-(1->2)-beta-D-Galp D-glucitol

alpha-L-Fucp-(1->2)-beta-D-Galp D-glucitol Show first 5 Terms

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-D-Glu-OH

Phenotype where environments contain alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-D-Glu-OH

Phenotype modified by environments containing alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-D-Glu-OH

Human Disease Model